Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$2.49B |
| 2 |
Alcon
ALC
|
+$805M |
| 3 |
Bank of America
BAC
|
+$662M |
| 4 |
RTN
Raytheon Company
RTN
|
+$621M |
| 5 |
Dow Inc
DOW
|
+$575M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.18B |
| 2 |
Wells Fargo
WFC
|
+$1.01B |
| 3 |
Qualcomm
QCOM
|
+$860M |
| 4 |
American Tower
AMT
|
+$688M |
| 5 |
Alibaba
BABA
|
+$651M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.08% |
| 2 | Financials | 14.73% |
| 3 | Technology | 14.09% |
| 4 | Industrials | 10.91% |
| 5 | Consumer Discretionary | 9.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Rigel Pharmaceuticals
RIGL
$681M
| $60.8M | 0.01% |
2,331,138
-7,710
| -0.3% | -$174K |
|
702
Expeditors International
EXPD
$22B
| $60.8M | 0.01% |
801,792
-23,865
| -3% | -$1.8M |
|
|
XLRN
703
DELISTED
Acceleron Pharma
XLRN
| $60.7M | 0.01% |
1,478,314
+10,035
| +0.7% | +$415K |
|
704
Moog Inc Class A
MOG.A
$12.4B
| $60.7M | 0.01% |
648,256
-50,658
| -7% | -$4.51M |
|
705
CRISPR Therapeutics
CRSP
$4.73B
| $60.2M | 0.01% |
1,277,089
-177,541
| -12% | -$7.1M |
|
706
Gentherm
THRM
$1.24B
| $59.9M | 0.01% |
1,431,099
+30,309
| +2% | +$1.22M |
|
707
Avient
AVNT
$3.33B
| $59.7M | 0.01% |
1,902,275
+259,831
| +16% | +$7.28M |
|
708
Neurocrine Biosciences
NBIX
$16.8B
| $59.1M | 0.01% |
699,417
+631,711
| +933% | +$51.9M |
|
|
GSKY
709
DELISTED
GreenSky, Inc. Class A Common Stock
GSKY
| $59M | 0.01% |
6,421,067
-1,981,398
| -24% | -$25.9M |
|
|
FOE
710
DELISTED
Ferro Corporation
FOE
| $58.7M | 0.01% |
3,715,622
-1,423,495
| -28% | -$22.9M |
|
711
Ameris Bancorp
ABCB
$5.85B
| $58.6M | 0.01% |
1,495,762
+228,743
| +18% | +$8.35M |
|
712
Scorpio Tankers
STNG
$3.87B
| $58.5M | 0.01% |
1,981,577
-847
| -0% | -$21.4K |
|
713
Stepan Co
SCL
$1.46B
| $58.5M | 0.01% |
636,256
+116,850
| +22% | +$10.4M |
|
|
TCDA
714
DELISTED
Tricida, Inc. Common Stock
TCDA
| $57.6M | 0.01% |
1,459,074
+368,692
| +34% | +$13M |
|
715
Itaú Unibanco
ITUB
$93.2B
| $57.5M | 0.01% |
8,387,677
+7,529,995
| +878% | +$47.4M |
|
|
MFA
716
MFA Financial
MFA
$926M
| $57.5M | 0.01% |
2,001,296
+954,563
| +91% | +$27.9M |
|
717
Nordson
NDSN
$16.6B
| $57.4M | 0.01% |
406,288
+14,296
| +4% | +$1.97M |
|
718
Cohu
COHU
$2.26B
| $57.3M | 0.01% |
3,710,641
+246,108
| +7% | +$3.83M |
|
|
CBIO
719
Crescent Biopharma
CBIO
$535M
| $56.8M | 0.01% |
47,623
-2,024
| -4% | -$2.42M |
|
720
SBA Communications
SBAC
$19.2B
| $56.7M | 0.01% |
252,181
-80,742
| -24% | -$17M |
|
|
IBTX
721
DELISTED
Independent Bank Group, Inc.
IBTX
| $56.5M | 0.01% |
1,028,329
-27,591
| -3% | -$1.5M |
|
722
Ares Management
ARES
$28.9B
| $56.5M | 0.01% |
+2,159,009
| New | +$54.8M |
|
723
Devon Energy
DVN
$52.1B
| $56.4M | 0.01% |
1,977,242
-393,590
| -17% | -$11.7M |
|
724
Sea Limited
SE
$65.4B
| $56.4M | 0.01% |
1,696,537
-180,437
| -10% | -$4.89M |
|
725
Gold Fields
GFI
$29B
| $55.7M | 0.01% |
10,303,528
+4,938,871
| +92% | +$21.1M |
|
Similar funds
Wellington Management Group's Q2 2019 Portfolio in Review
As of Q2 2019, Wellington Management Group held 2,200 positions worth $452B, up 2.3% from $442B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Wellington Management Group's Q2 2019 filing shows 165 new, 807 increased, 919 reduced and 161 closed positions. Its largest new stake was Alcon: 13,706,926 shares worth $848M. The largest sale was DuPont de Nemours, an estimated $1.18B.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 22% a quarter earlier, followed by Financials and Technology.
- Wellington Management Group's largest Q2 2019 buy was Alcon: 13,706,926 shares worth $848M.
- Wellington Management Group added most to Pfizer in Q2 2019, an estimated $2.49B increase.
- Wellington Management Group's biggest Q2 2019 reduction was DuPont de Nemours, cutting an estimated $1.18B.
- Wellington Management Group fully exited Zillow in Q2 2019, selling an estimated $189M.
- Wellington Management Group's ten largest holdings make up 15% of its $452B portfolio in Q2 2019.
- Wellington Management Group opened 165 new positions and closed 161 in Q2 2019.
- Wellington Management Group's portfolio value rose 2.3% quarter-over-quarter to $452B.
Based on Wellington Management Group's 13F filing for Q2 2019, filed 14 Aug 2019.